La Zecca e il doppio bollino sui farmaci, lo strano spreco da 60 milioni di euro

Italy will implement a dual labeling system for medicines starting February 9, a unique case in Europe alongside Greece. This new regulation is causing challenges for the pharmaceutical supply chain, with major companies warning of potential delays in product availability. The complexity of the system raises concerns about its impact on both manufacturers and consumers, as it may lead to confusion and inefficiencies in the market.